Latest News for: seika
Edit
Meiji Seika Pharma：Announcement of the Establishment of Local Subsidiary "Meiji Pharma Asia Pte. Ltd." in Singapore (Meiji Holdings Co Ltd)
Public Technologies 23 Dec 2025
December 23, 2025 Meiji Seika Pharma：Announcement of the Establishment of Local Subsidiary "Meiji Pharma Asia Pte ... Meiji Seika Pharma Co., Ltd ... Wholly owned subsidiary of Meiji Seika Pharma Co., Ltd.
Edit
The Milton Standard Journal
19 Dec 2025
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery
Edit
The Eagle-Tribune
03 Dec 2025
Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing
Edit
Meiji Seika Pharma Initiates Research Collaboration with National Cancer Center on Novel Solid Tumor Therapy Applying Self-amplifying mRNA Vaccine (Meiji Holdings Co Ltd)
Public Technologies 12 Nov 2025
Edit
Meiji Seika Pharma to Establish a Local Subsidiary in Singapore to Expand its Business in the ASEAN Region (Meiji Holdings Co Ltd)
Public Technologies 11 Nov 2025
Edit
Meiji Seika Pharma Launches Two-Dose Vial of KOSTAIVE®, a Self-Amplifying mRNA COVID-19 Vaccine, in Japan (Meiji Holdings Co Ltd)
Public Technologies 26 Sep 2025
). September 26, 2025 Meiji Seika Pharma Launches Two-Dose Vial of KOSTAIVE®, a Self-Amplifying mRNA COVID-19 Vaccine, in Japan. Meiji Seika Pharma Co., Ltd ... Meiji Seika Pharma remains committed to contributing to the prevention of COVID-19 ... Brand Name.
Edit
Meiji Seika Pharma Launches Two-Dose Vial of KOSTAIVE®, a Self-Amplifying mRNA COVID-19 Vaccine, in Japan (Form 8-K) (Arcturus Therapeutics Holdings Inc)
Public Technologies 26 Sep 2025- 1